Sandostatin

Medicinal product

(Invented) name

Sandostatin

Active substance (s)

Oktreotidas

Strength

100 µg/ml

Pharmaceutical form

injekcinis ar infuzinis tirpalas

Route (s) of administration

leisti į veną, leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

H01CB02, Octreotide

Marketing authorisation holder

SIA Novartis Baltics, Latvija

Date of authorisation

1994-03-31

Date of renewal

2008-02-22

Documents

1033 Pakuotės lapelis inj_inf 2024 10 09.docx

1033 Sandostatin inj_inf II PL 2024 10 09.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

DE/H/5095/002

Marketing authorisation procedure

Savitarpio pripažinimo procedūra

Qualitative and quantitative composition

1 ml tirpalo yra	1 ml
Oktreotidas	100 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
2191	7829	1007829	ampulė	1 ml N5		Receptinis	LT/1/94/1033/001	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2008-02-22	Perregistruotas
1994-03-31	Registruotas